RARECast

RARECast

By RARECastBusiness
Download on the App Store

RARECast episodes

  • Moving Rare Disease Therapies from Hope to Reality
    World Rare Disease Day, an annual international effort to create awareness for rare diseases, will take place February 28. This year, the theme is on how research brings hope to people living with rare diseases. This seemed like an opportune time to talk to Kenneth Hobby, president of CureSMA, about his organization’s efforts to drive research for spinal muscular atrophy, the most common genetic cause of death for infants. We spoke to Hobby about CureSMA’s strategy for research, the role the group played in helping to make possible the first approved therapy for the disease at the end of last year, and what other rare disease organizations can learn from its experience.
    21 min
  • Children’s National Launches First-of-its-Kind Rare Disease Center
    Last month, Children's National Health System, the world’s largest provider of care for children with rare genetic disorders, announced the formation of Children’s National Rare Disease Institute. Billed as a first-of-its-kind center focused exclusively on advancing the care and treatment of children and adults with rare genetic diseases, the National Organization for Rare Disorders has designated it as its first Center of Excellence of Clinical Care for Rare Diseases. We spoke to Marshall Summar, chief of Genetics and Metabolism at Children’s National and chairman of NORD, about the new institute, the ambitious vision for it, and the role it hopes to play in transforming care for people with rare diseases.
    23 min
  • A Common Link in a Group of Rare Diseases Creates an Opportunity for Repurposing
    A group of rare, genetic, metabolic diseases known as lysosomal storage disorders are largely without treatments. Mark Noble believes one way of accelerating the development of therapies for this group of disorders is to look at them collectively instead of individually, and see whether existing drugs might serve as treatments. Noble, professor of Genetics and of Neurobiology and Anatomy at the University of Rochester Medical Center, recently co-authored a study in PLoS Biology (http://bit.ly/2kPbUzJ) that suggests repurposed drugs could address a common aspect of these diseases and provide therapeutic benefit. We spoke to Noble about his research, the findings of this common link in this group of diseases, and the potential implications for using already approved drugs to bring needed treatments to patients.
    20 min
  • Sobi Works to Expand Rare Disease Indications for Its Drugs
    Sobi is a drugmaker focused on hemophilia, inflammation, and genetic and metabolic diseases. It is now pursuing its drug Orfadin, used to treat the metabolic disorder tyrosemia type 1, as a potential treatment for the metabolic condition alkaptonuria. It is also pursuing Kineret, its drug for the rare inflammatory condition NOMID, as a potential therapy for Still’s disease. We spoke to Rami Levin, president of North America for Sobi, and Len Walt, vice president and head of medical affairs of North America for Sobi, about the company’s evolution, its growing pipeline, and its effort to expand indications for its rare disease drugs.
    28 min
  • Why Rare Disease Patients Should Work Together to Address Common Concerns
    The large number of rare diseases and the small number of patients afflicted with any one of them can help fuel a sense of isolation these patients feel. Sandra Shpilberg, CEO of Seeker Health, has interviewed many rare disease patients over time as part of her work to help drugmakers find participants for clinical trials. In a recent article on her website she argues that rare disease patients, regardless of their particular ailment, share much in common. We spoke to Shpilberg about the disease burden that rare disease patients face, how they may seek to address some of these issues, and why collaboration throughout the rare disease community is critical to creating better outcomes.
    20 min
  • Solving Medical Mysteries with the Wisdom of Crowds
    The search for a diagnosis can be a long and difficult journey for patients with a rare disease, but CrowdMed is offering a different way for them to find the answers they seek. The web-based service allows patients to tap a multidisciplinary team of experts to help them solve their medical mysteries. We spoke to Jared Heyman, founder and CEO of CrowdMed about the service, how his the experience his sister faced in getting a diagnosis for a rare disease led to its creation, and why the company, even though its backed by top-flight investors, is now turning to crowdfunding to raise capital.
    26 min
  • Embracing Collaborations to Drive Development of Rare Disease Therapies
    Collaborations have become a critical aspect of the search for new treatments for rare diseases as drug companies, universities, research institutes, and patient groups are forging alliances to leverage their strengths. Outside this year’s J.P. Morgan Healthcare Conference, Global Genes will convene Rare in the Square in San Francisco’s Union Square to provide rare-disease focused companies and organizations a place to network at the heart of the week’s activities. We spoke to Michael Pistone, director of marketing, innovation & commercialization at Cincinnati Children’s Hospital Medical Center, about his hospital’s rare disease partnerships with drug companies, how the face of partnering in the rare disease space is evolving, and what he’s hoping for at this year’s Rare in the Square event.
    18 min
  • Determining If a Child's Neurologic or Psychiatric Symptoms are Caused by an Infection
    Obsessive compulsive disorder, tics, anxiety, attention deficit hyperactivity disorder, and behaviors associated with autism spectrum disorders can be caused by a treatable autoimmune condition that is triggered by common infections. These conditions, known as PANDAS and PANS can often be misdiagnosed and wrongly treated to the detriment of the children with the condition. We spoke to Craig Shimasaki, CEO of Moleculera Labs, which has developed a diagnostic to determine if an individual’s neurologic or psychiatric symptoms could be caused by an autoimmune dysfunction. Shimasaki discussed these conditions, what we know about them, and how the availability of a diagnostic is helping change the way these patients are understood and treated. This is an encore presentation of an interview that first aired in April 2016.
    19 min
  • Helping Patients with the Same Undiagnosed Genetic Condition Find Each Other
    For rare disease patients and their families, genome and exome sequencing may identify mutations that may be drivers of a condition, but nothing more. As families search for a name to put to a disease and look for treatments, finding others with the same condition and researchers working to understand and treat it becomes a critical part of the search for answers. Now researchers at the University of Washington have created MyGene2, a web portal for people with rare genetic mutations to connect with others with the same condition and researchers interested in their particular mutation. We spoke to Michael Bamshad, professor and chief of the Division of Genetic Medicine in the Department of Pediatrics at the University of Washington & Seattle Children’s Hospital, and Jessica Chong, one of the leads on the MyGene2 project at the Center for Mendelian Genomics at the University of Washington, about the portal, how it works, and what they are hoping to accomplish. This is an encore of an interview that first aired April 2016.
    19 min
  • An Entrepreneur Uses a Silicon Valley Approach to Tackle Rare Disease
    When Matt Wilsey daughter Grace was diagnosed with the ultra rare disease NGLY1 deficiency, he travelled the world to get a diverse group of researchers to work on finding answers. His approach to driving research, he says, comes from his experience as a Silicon Valley entrepreneur. We spoke to Wilsey about the experience getting a diagnosis for his daughter, what he learned from others who had gone before him, and the importance of open collaboration across institutions.
    29 min

About RARECast

From the publisher's feed

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.